NIH Loses in Court; NSYNC Member’s New Diagnosis; Chief Resident Dies at 32

Note that some links may require registration or subscription.

A federal appeals court ruled that the NIH’s ban on social media comments about animal testing violated free speech rights. (Washington Post)

The British Medical Association announced plans to evaluate the Cass Review — the U.K. report that determined there was weak evidence to support puberty blockers in minors — and put a pause on the review’s recommendations.

A Commonwealth Fund survey found that 45% of insured American adults received a medical bill or a charge in the past year that they thought should have been covered.

Removing barriers to vaccine access and incentives showed the most promise for increasing vaccination uptake, according to a meta-analysis in Nature.

Some ob/gyn residents in the U.S. are receiving less abortion care training as pregnancy complications rise, an investigation by House Democrats found. (NBC News)

Two couples dropped their lawsuit against an Alabama hospital and an in vitro fertilization clinic over the accidental destruction of frozen embryos. (AP)

Australian pathologist Robin Warren, MD, who shared a Nobel Prize for helping show that Helicobacter pylori causes ulcers, died at age 87. (Washington Post)

NSYNC member Lance Bass clarified that he has latent autoimmune diabetes in adults, sometimes called type 1.5 diabetes. (People)

Massachusetts Gov. Maura Healey (D) pressed Steward Health Care to adhere to a state regulation requiring 120 days notice before a medical facility can close. (AP)

Medicare reimbursements to inpatient hospitals will increase 2.9% in fiscal year 2025, according to a final CMS rule.

Olympics got you nervous? NBC uses monitors to track the heart rates of spectating Olympic parents. (Washington Post)

The FDA expanded the approval for dostarlimab (Jemperli) plus chemotherapy followed by single-agent dostarlimab in primary advanced or recurrent endometrial cancer.

And the agency also granted a new indication to fibrinogen concentrate (Fibryga) for supplementation in bleeding patients with acquired fibrinogen deficiency, said drugmaker Octapharma.

Across three states from August 2022-July 2023, the veterinary anesthetic medetomidine was detected in five of 1,331 blood samples of people evaluated for suspected opioid overdose, according to a CDC report.

Eli Lilly’s diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) will come out of shortage “very soon,” the company’s CEO said. (Reuters)

Maddie Giegold, MD, chief resident at a California medical center, died of a stroke at age 32, just days before completing her residency. (KFSN)

Amazon is legally responsible for recalling dangerous products and informing the public, the Consumer Product Safety Commission said.

An ammonia gas leak at a commercial building in Virginia sent 26 people to the hospital. (Newsweek)

A patient allegedly stabbed a nurse and injured several others with a hypodermic needle at Temple University Hospital’s Episcopal Campus in Philadelphia. (WPVI)

Two infant boys died in hot cars on the same day in separate states, bringing the total of such deaths to 17 this year in the U.S. (ABC News)